ECSP056039A - PERORAL PHARMACEUTICAL FORMULATION FOR PROTECTION PUMP ANTAGONIST AGENTS - Google Patents

PERORAL PHARMACEUTICAL FORMULATION FOR PROTECTION PUMP ANTAGONIST AGENTS

Info

Publication number
ECSP056039A
ECSP056039A EC2005006039A ECSP056039A ECSP056039A EC SP056039 A ECSP056039 A EC SP056039A EC 2005006039 A EC2005006039 A EC 2005006039A EC SP056039 A ECSP056039 A EC SP056039A EC SP056039 A ECSP056039 A EC SP056039A
Authority
EC
Ecuador
Prior art keywords
pharmaceutical formulation
antagonist agents
pump antagonist
protection pump
peroral pharmaceutical
Prior art date
Application number
EC2005006039A
Other languages
Spanish (es)
Inventor
Rango Dietrich
Hartmut Ney
Simone Hiltl
Bernd-Michael Haas
Original Assignee
Altana Pharma A G
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Altana Pharma A G filed Critical Altana Pharma A G
Publication of ECSP056039A publication Critical patent/ECSP056039A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4375—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having nitrogen as a ring heteroatom, e.g. quinolizines, naphthyridines, berberine, vincamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

El invento se refiere a nuevas formas de dosificación para agentes antagonistas de bombas de protones.The invention relates to new dosage forms for proton pump antagonist agents.

EC2005006039A 2003-04-11 2005-09-26 PERORAL PHARMACEUTICAL FORMULATION FOR PROTECTION PUMP ANTAGONIST AGENTS ECSP056039A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10317023A DE10317023A1 (en) 2003-04-11 2003-04-11 Oral dosage form useful in the treatment and prevention of gastrointestinal disorders e.g. inflammatory disorders and lesions such as gastric ulcer comprises proton pump inhibitor and basic excipients

Publications (1)

Publication Number Publication Date
ECSP056039A true ECSP056039A (en) 2006-01-27

Family

ID=33154195

Family Applications (1)

Application Number Title Priority Date Filing Date
EC2005006039A ECSP056039A (en) 2003-04-11 2005-09-26 PERORAL PHARMACEUTICAL FORMULATION FOR PROTECTION PUMP ANTAGONIST AGENTS

Country Status (3)

Country Link
CN (1) CN1767817A (en)
DE (1) DE10317023A1 (en)
EC (1) ECSP056039A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10835541B2 (en) 2015-07-30 2020-11-17 Takeda Pharmaceutical Company Limited Tablet

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104027344B (en) * 2014-06-20 2016-08-24 新乡医学院 Comprise the pharmaceutical composition of lincomycin
CN111184867A (en) * 2020-03-19 2020-05-22 龚跃明 Chemical medicine composition for treating helicobacter pylori infection

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10835541B2 (en) 2015-07-30 2020-11-17 Takeda Pharmaceutical Company Limited Tablet

Also Published As

Publication number Publication date
CN1767817A (en) 2006-05-03
DE10317023A1 (en) 2004-11-11

Similar Documents

Publication Publication Date Title
CY1120377T1 (en) SOLID PHARMACEUTICAL DOSAGE PHARMACEUTICAL FORM CONTAINING LOPINAVIR
AR095848A2 (en) IMIDAZOLIC DERIVATIVES OF PROPIONAMIDE MODULATORS OF OPIOID RECEPTORS
BRPI0417717A (en) compound, pharmaceutical composition, and use of a compound
DK1521573T3 (en) Non-polymeric, lipophilic, pharmaceutical implant compositions for intracellular use
BRPI0606339A2 (en) alcohol resistant dosage forms
UY29562A1 (en) AMINO BENZOIL HETEROCYCLIC COMPOUNDS, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, PREPARATION PROCEDURES AND APPLICATIONS
NO20052739D0 (en) CCR5 antagonists as drugs
CR9772A (en) ISOINDOL-IMIDA COMPOUNDS AND COMPOSITIONS THAT INCLUDE IT AND METHODS TO USE THE SAME
MXPA05012463A (en) Pharmaceutical combinations of a proton pump inhibitor and a compound which modifies gastrointestinal motility.
CO6362017A2 (en) THERAPEUTIC ANTIVIRAL PEPTIDES
BRPI0815894A2 (en) PHARMACEUTICAL COMPOSITION, USE OF THE SAME, AND PHARMACEUTICALLY ACCEPTABLE SALTS OF A COMPOUND.
UY29561A1 (en) DERIVATIVES OF QUINAZOLINE, PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM, PREPARATION PROCEDURES AND APPLICATIONS
NO20080219L (en) Fentanyl formulation containing an essential oil
NO20063393L (en) Pharmaceutical preparations
DK1624869T3 (en) DOSAGE FORM CONTAINING PANTOPRAZOL AS ACTIVE INGREDIENT
EA200600953A1 (en) DOSED FORMS OF TORECEMIDA OF PROLONGED DELIVERY
DK1814848T3 (en) 2,3,4-substituted-cyclopentanones as therapeutic agents
BRPI0417265A (en) pharmaceutical composition comprising an active ingredient and sulfobetaine
NO20055207L (en) Oral pharmaceutical preparation for proton pump antagonists
EP1900368A4 (en) TABLET CONTAINING AN ACTIVE SOLUBLE INGREDIENT
NO20063293L (en) Pharmaceutical compounds
ITMI20050477A1 (en) TRANSDERMIC PATCH
EA200901387A1 (en) PHARMACEUTICAL COMPOSITION INCLUDING DESLORATADINE
DK1420789T3 (en) Use of active substances with myopioid receptor agonist and opioid receptor antagonist effect as combination drugs for cancer treatment
ATE529432T1 (en) AZAZYKLOSTEROID AS A LIGAND OF THE HISTAMINE-3 RECEPTORS